Comparative study of autophagy inhibition by 3MA and CQ on Cytarabine-induced death of leukaemia cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative study of autophagy inhibition by 3MA and CQ on Cytarabine-induced death of leukaemia cells

Published:2014-03-22 Issue:6 Volume:140 Page:909-920
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Palmeira-dos-Santos Caroline,Pereira Gustavo J. S.,Barbosa Christiano M. V.,Jurkiewicz Aron,Smaili Soraya S.,Bincoletto Claudia

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-014-1640-4.pdf

Reference51 articles.

1. Ablain J, Leiva M, Peres L, Fonsart J, Anthony E, de Thé H (2013) Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies. J Exp Med 210:647–653

2. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI et al (2007) Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 117:326–336

3. Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N, Timmer W et al (2011) Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 17:654–665

4. Arranz R, García-Noblejas A, Grande C, Cannata-Ortiz J, Sánchez JJ, García-Marco JA et al (2013) First line treatment with rituximab- Hyper-CVAD alternating with rituximab- Methotrexate- Cytarabine and followed by consolidation with 90Y-Ibritumomab-Tiuxetan in patients with mantle cell lymphoma. Results of a phase 2 pilot multicenter trial from the GELTAMO group. Haematologica 98:1563–1570

5. Bincoletto C, Bechara A, Pereira GJ, Santos CP, Antunes F, Peixoto da-Silva J et al (2013) Interplay between apoptosis and autophagy, a challenging puzzle: new perspectives on antitumor chemotherapies. Chem Biol Interact 206:279–288

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Tumor-promotional Molecular Axis CircMAPKBP1/miR-17-3p/TGFβ2 Activates Autophagy Pathway to Drive Tongue Squamous Cell Carcinoma Cisplatin Chemoresistance;Cancer Letters;2024-09

2. Enhancing Therapeutic Efficacy in Cancer Treatment: Integrating Nanomedicine with Autophagy Inhibition Strategies;ACS Omega;2024-06-18

3. Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies;Signal Transduction and Targeted Therapy;2023-12-18

4. Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance;Cell Death Discovery;2023-07-06

5. ATB0,+-targeted nanoparticles initiate autophagy suppression to overcome chemoresistance for enhanced colorectal cancer therapy;International Journal of Pharmaceutics;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3